Old Mission Capital’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-13,904
Closed -$1.25M – 1266
2024
Q4
$1.25M Buy
13,904
+11,496
+477% +$1.11M 0.02% 315
2024
Q3
$238K Sell
2,408
-62,978
-96% -$6.19M ﹤0.01% 1048
2024
Q2
$6.06M Buy
+65,386
New +$5.86M 0.1% 157
2024
Q1
– Sell
-6,595
Closed -$589K – 1647
2023
Q4
$589K Buy
+6,595
New +$490K 0.01% 715
2023
Q3
– Sell
-23,243
Closed -$1.93M – 1600
2023
Q2
$1.93M Buy
+23,243
New +$1.94M 0.04% 288
2022
Q3
– Sell
-88,243
Closed -$6.55M – 1381
2022
Q2
$6.55M Buy
88,243
+19,491
+28% +$1.46M 0.18% 102
2022
Q1
$6.18M Buy
+68,752
New +$6.35M 0.17% 87
2021
Q1
– Sell
-16,803
Closed -$2.37M – 915
2020
Q4
$2.37M Sell
16,803
-56,821
-77% -$7.28M 0.15% 132
2020
Q3
$8.2M Buy
73,624
+43,435
+144% +$4.87M 0.65% 30
2020
Q2
$3.38M Buy
+30,189
New +$2.97M 0.24% 76
2020
Q1
– Sell
-16,264
Closed -$1.55M – 514
2019
Q4
$1.55M Buy
+16,264
New +$1.41M 0.12% 127
2019
Q3
– Sell
-8,600
Closed -$754K – 344
2019
Q2
$754K Buy
+8,600
New +$734K 0.09% 131
2019
Q1
– Sell
-60,256
Closed -$4.32M – 360
2018
Q4
$4.32M Buy
60,256
+55,956
+1,301% +$4.51M 0.44% 61
2018
Q3
$412K Buy
+4,300
New +$417K 0.07% 163
2017
Q1
– Sell
-4,858
Closed -$288K – 455
2016
Q4
$288K Buy
+4,858
New +$300K 0.02% 320

Other funds holding XBI

Old Mission Capital's XBI Position: Q1 2025 in Review

Old Mission Capital sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2025, closing a stake of 13,904 shares — an estimated $1.25M sold.

Old Mission Capital first reported a position in XBI in Q4 2016 and held it in 15 quarters. The position peaked at $8.2M in Q3 2020. 685 funds tracked by Wall St. Rank hold XBI as of Q1 2025.

  • Old Mission Capital reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2025 after selling out during the quarter.
  • Old Mission Capital sold 13,904 State Street SPDR S&P Biotech ETF shares in Q1 2025, an estimated $1.25M.
  • Old Mission Capital first reported a position in State Street SPDR S&P Biotech ETF in Q4 2016 and held it in 15 quarters.
  • Old Mission Capital's State Street SPDR S&P Biotech ETF position peaked at $8.2M in Q3 2020.
  • 685 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2025.

Based on Old Mission Capital's 13F filing for Q1 2025, filed 15 May 2025.